Ematologia – Molte novità terapeutiche ma è difficile stabilire se una terapia è migliore di un’altra. EmatoBase.it aiuta l’ematologo a fare scelte basate sull’evidenza
Riservato agli Ematologi – La terapia farmacologica e cellulare è in continua evoluzione. Molti farmaci si contendono le stesse indicazioni. Dagli studi clinici stanno emergendo i vantaggi di efficacia e di sicurezza di alcuni verso altri. Iniziano anche a comparire i primi studi head-to-head
LA FONTE DI INFORMAZIONE PRIMARIA IN MEDICINA E’ RAPPRESENTATA DAGLI STUDI PUBBLICATI SU RIVISTE SCIENTIFICHE PEER REVIEWED
Tuttavia, l’EMATOLOGO ha sempre meno tempo da dedicare alla lettura delle Riviste scientifiche.
Xagena propone i propri DATABASE consultabili come un classico motore di Ricerca ( EmatoBase.it ) … un Sistema Easy & Fast di AGGIORNAMENTO ONLINE ON DEMAND SU SPECIFICI TEMI
EMATOBASE.it – DECISION MAKING IN EMATOLOGIA – L’IMPORTANZA DEI CONTENUTI NELL’ASSUNZIONE DELLE DECISIONI TERAPEUTICHE
Esempi ( Contenuti IN PROGRESS )
1 – Acalabrutinib [ LINK: https://lnkd.in/dGdWDgzz ]
2 – Asciminib [ LINK: //https://lnkd.in/d8mME7Ku ]
3 – Axicabtagene ciloleucel [ LINK: https://lnkd.in/eZtrm_ew ]
4 – Belantamab mafodotin [ LINK: https://lnkd.in/eVFpP4MR ]
5 – Blinatumomab [ LINK: https://lnkd.in/dvrTTYRb ]
6 – Brentuximab vedotin [ LINK: https://lnkd.in/dNwZJNPj ]
7 – Brexucabtagene autoleucel [ LINK: https://lnkd.in/dDW8ZyeX ]
8 – Carfilzomib [ LINK: https://lnkd.in/eCYwd_ys ]
9 – Daratumumab [ LINK: https://lnkd.in/dNipUqik ]
10 – Elotuzumab [ LINK: https://lnkd.in/dZvViQvA ]
11 – Elranatamab [ LINK: https://lnkd.in/dXP87p8k ]
12 – Epcoritamab [ LINK: https://lnkd.in/dgBd2DNb ]
13 – Fedratinib [ LINK: https://lnkd.in/dsTTz3Nc ]
14 – Gilteritinib [ LINK: https://lnkd.in/eBW45g3P ]
15 – Glofitamab [ LINK: https://lnkd.in/dr4QinPu ]
16 – Ibrutinib [ LINK: https://lnkd.in/dARjbKFT ]
17 – Inotuzumab Ozogamicin [ LINK: https://lnkd.in/dinDC7Qe ]
18 – Isatuximab [ LINK: https://lnkd.in/epAgJuMu ]
19 – Ixazomib [ LINK: https://lnkd.in/dFP4Hxuc ]
20 – Lenalidomide [ https://lnkd.in/eFxf_aN3 ]
21 – Lisocabtagene maraleucel [ LINK: https://lnkd.in/dEXumKq2 ]
22 – Loncastuximab tesirina [ LINK: https://lnkd.in/djeMuBnC ]
23 – Magrolimab [ LINK: https://lnkd.in/dhcB3ZA4 ]
24 – Momelotinib [ LINK: https://lnkd.in/dDndWwP5 ]
25 – Mosunetuzumab [ LINK: https://lnkd.in/dPpsCdHc ]
26 – Pirtobrutinib [ LINK: https://lnkd.in/d8y9e6bS ]
27 – Pomalidomide [ LINK: https://lnkd.in/dx4zMt4M ]
28 – Ropeginterferone alfa-2b [ LINK: https://lnkd.in/dNuDaDFC ]
29 – Talquetamab [ LINK: https://lnkd.in/dNrZeHUQ ]
30 – Teclistamab [ LINK: https://lnkd.in/dGDZGe_6 ]
31 – Tisagenlecleucel [ LINK: https://lnkd.in/dvEhZvrB ]
32 – Venetoclax [ LINK: https://lnkd.in/d2nTKvmw ]
33 – Zanubrutinib [ LINK: https://lnkd.in/dgiusjGy ]
–
+++++++++++++++++++++++++++++++++++++++++++++++++
